Jaramillo’s promotion was effective July 1.
Jaramillo has been at the Eden Prairie, Minn.-based fluid overload treatment developer since May 2019, focusing on commercial growth.
“Nestor has had a strong impact on our commercial success over the last 14 months,” said CHF Solutions CEO John Erb.
“Under Nestor’s leadership, we have expanded our strategy into critical care and pediatrics, including the recent launch of the Aquadex SmartFlow system for use in adult and pediatric patients weighing over 20 kg. I look forward to continuing to work with Nestor as the company improves the lives of patients suffering from fluid overload,” Erb said in a June 25 news release.
Before CHF, Jaramillo was president and CEO of Innerspace Neuro Solutions, a commercial-stage medtech company that developed, manufactured, and distributed an intracranial pressure monitoring system.